Fibrocell to Present at 6th Annual Cell & Gene Therapy Investor Day and 2018 World Orphan Drug Congress USAGlobeNewswire (press release)EXTON, Pa., April 10, 2018 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company foc… Continue reading
|
HealthWatch: Fighting Parkinson’s With Deep Sea Shrimp and CRISPR
WeAreGreenBay.com A gene editing system called CRISPR allows them to “light up” a protein in the brain associated with Parkinson’s. Levi Adams, a Doctoral Student at the Burnett School of Biomedical Sciences, said, “In this study we are working with a protein that was … |
Nasdaq |
FOCUS-Lonza’s virus factory shows gene therapy’s Texas-sized promise
Nasdaq ZURICH, April 10 (Reuters) – Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution. The 121-year-old Basel-based contract manufacturer … |
Nasdaq |
FOCUS-Lonza’s virus factory shows gene therapy’s Texas-sized promise
Nasdaq ZURICH, April 10 (Reuters) – Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution. The 121-year-old Basel-based contract manufacturer … |
Reuters |
Lonza’s virus factory shows gene therapy’s Texas-sized promise
Reuters But the Association of the British Pharmaceutical Industry estimates the global cell and gene therapy market will be worth up to $21 billion annually by 2025. Pharmaceutical and biotechnology companies are racing to develop therapies that rely on … |